Counter-intuitive… hmmm_老虎社区_美港股上老虎

2021-06-25

Counter-intuitive… hmmm

Rite Aid shares plummet; CEO cites Covid uncertainty for drug store chain’s cautious outlook

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":126448159,"tweetId":"126448159","gmtCreate":1624582872671,"gmtModify":1633950985402,"author":{"id":3559859558754319,"idStr":"3559859558754319","authorId":3559859558754319,"authorIdStr":"3559859558754319","name":"Bodoh","avatar":"https://static.tigerbbs.com/349218ea2852130ca86ce660b4aa2d59","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":143,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Counter-intuitive… hmmm</p></body></html>","htmlText":"<html><head></head><body><p>Counter-intuitive… hmmm</p></body></html>","text":"Counter-intuitive… hmmm","highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/126448159","repostId":1182579765,"repostType":4,"repost":{"id":"1182579765","kind":"news","pubTimestamp":1624581841,"share":"https://www.laohu8.com/m/news/1182579765?lang=&edition=full","pubTime":"2021-06-25 08:44","market":"us","language":"en","title":"Rite Aid shares plummet; CEO cites Covid uncertainty for drug store chain’s cautious outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1182579765","media":"CNBC","summary":"Rite Aid CEO Heyward Donigan told CNBC on Thursday she's \"cautiously optimistic\" the U.S. can avoid ","content":"<div>\n<p>Rite Aid CEO Heyward Donigan told CNBC on Thursday she's \"cautiously optimistic\" the U.S. can avoid another round of strict Covid restrictions despite the presence of thedelta variant.\n\"We all hope ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/24/rite-aid-plummets-ceo-heyward-donigan-cites-covid-for-cautious-outlook.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rite Aid shares plummet; CEO cites Covid uncertainty for drug store chain’s cautious outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRite Aid shares plummet; CEO cites Covid uncertainty for drug store chain’s cautious outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 08:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/24/rite-aid-plummets-ceo-heyward-donigan-cites-covid-for-cautious-outlook.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Rite Aid CEO Heyward Donigan told CNBC on Thursday she's \"cautiously optimistic\" the U.S. can avoid another round of strict Covid restrictions despite the presence of thedelta variant.\n\"We all hope ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/24/rite-aid-plummets-ceo-heyward-donigan-cites-covid-for-cautious-outlook.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RAD":"来德爱"},"source_url":"https://www.cnbc.com/2021/06/24/rite-aid-plummets-ceo-heyward-donigan-cites-covid-for-cautious-outlook.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1182579765","content_text":"Rite Aid CEO Heyward Donigan told CNBC on Thursday she's \"cautiously optimistic\" the U.S. can avoid another round of strict Covid restrictions despite the presence of thedelta variant.\n\"We all hope that enough people get vaccinated that we don't have the variant become so significant that our markets shut down again,\" Donigan said on\"Squawk Box.\"\nEven so, the chief executive said the drug store chain was being judicious with its financial projections due, in part, to how unpredictable thecoronavirus pandemic's impact on business has been.\nShares of Rite Aid tumbled 14.5% on Thursday, sending the company's stock market value under $1 billion, as Wall Street digestedmixed first-quarter resultsand weaker earnings guidance.\nRite Aid's forecast for adjusted EBITDA — earnings before interest, taxes, depreciation and amortization — came in at $440 million to $480 million for fiscal 2022, below estimates of $524 million, according to FactSet.\n\"We're being very cautious because we had a miss last quarter due to the complete meltdown, I'll call it, of cough, cold, flu — both in the pharmacy and in the front end because there just was no cough, cold, flu,\" Donigan said, alluding to the recentsurprisingly calm flu seasonin the U.S. and its impact on Rite Aid.\n“We just didn’t realize how far down, how evaporated that business would actually be. So as we look forward, we think we need to be very cautious and prudent in our guidance,” said Donigan, who has been CEO of Pennsylvania-based Rite Aid since August 2019.\n“We are expecting some improvement. We’re not expecting full improvement,” Donigan added.\nShe also acknowledged, “It’s very hard, it remains very hard to predict, a full-year result in a retail pharmacy in the middle of a pandemic because we are … still in the throes of this to some degree.”\nThe company projected full-year revenue of between $25.1 billion and $25.5 billion, which exceeded Wall Street’s expectations of $24.66 billion, according to FactSet.\nRite Aid’s outlook is not factoring inpotential Covid vaccine boostersor vaccinations for children under the age of 12, Donigan noted. Trials examining the vaccine in kids under age 12 are currently ongoing.\nThe Food and Drug Administration cleared Pfizer’s Covid vaccine for use in kids ages 12 to 15a little more than a month ago. Moderna, which also makes a two-dose vaccine, has asked the FDA to expand its emergency use authorization to cover adolescents from 12 to 17.","news_type":1},"isVote":1,"tweetType":1,"viewCount":62,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":22,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/126448159"}